BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57 | -89.2% | 8,064 | -87.3% | 0.00% | – |
Q1 2023 | $528 | +14.8% | 63,313 | +58.0% | 0.00% | -100.0% |
Q4 2022 | $460 | -100.0% | 40,082 | -54.1% | 0.00% | 0.0% |
Q2 2022 | $923,000 | -14.2% | 87,260 | +31.8% | 0.00% | 0.0% |
Q1 2022 | $1,076,000 | +1663.9% | 66,185 | +1397.4% | 0.00% | – |
Q4 2021 | $61,000 | -92.7% | 4,420 | -91.5% | 0.00% | -100.0% |
Q3 2021 | $841,000 | +0.4% | 51,735 | -2.4% | 0.00% | 0.0% |
Q2 2021 | $838,000 | – | 53,009 | +33.0% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 39,871 | -84.1% | 0.00% | -100.0% |
Q4 2020 | $1,866,000 | +1996.6% | 250,512 | +859.2% | 0.00% | – |
Q3 2020 | $89,000 | +81.6% | 26,118 | +150.2% | 0.00% | – |
Q2 2020 | $49,000 | +390.0% | 10,439 | +259.6% | 0.00% | – |
Q4 2019 | $10,000 | -65.5% | 2,903 | -21.2% | 0.00% | – |
Q4 2018 | $29,000 | -47.3% | 3,682 | -49.5% | 0.00% | – |
Q3 2018 | $55,000 | -83.4% | 7,298 | -87.8% | 0.00% | -100.0% |
Q2 2017 | $331,000 | +845.7% | 59,614 | +1315.3% | 0.01% | +600.0% |
Q1 2017 | $35,000 | -82.8% | 4,212 | -86.9% | 0.00% | -83.3% |
Q4 2016 | $203,000 | +66.4% | 32,215 | +16.2% | 0.01% | +50.0% |
Q3 2016 | $122,000 | +3966.7% | 27,729 | +6849.6% | 0.01% | – |
Q1 2015 | $3,000 | +50.0% | 399 | +173.3% | 0.00% | – |
Q4 2014 | $2,000 | – | 146 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |